{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:58:36Z","timestamp":1793239116826,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002345","name":"Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TRR 338\/1 2021-452881907"],"award-info":[{"award-number":["SFB-TRR 338\/1 2021-452881907"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR338"],"award-info":[{"award-number":["TRR338"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"IMI","doi-asserted-by":"publisher","award":["853988"],"award-info":[{"award-number":["853988"]}],"id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016838","name":"Berlin Mathematical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016838","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008594","name":"European Hematology Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70114707"],"award-info":[{"award-number":["70114707"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","award":["Z-2_CSP_2022-27"],"award-info":[{"award-number":["Z-2_CSP_2022-27"]}],"id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Stem Cell"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.stem.2024.04.018","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T10:48:25Z","timestamp":1715770105000},"page":"989-1002.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-6871","authenticated-orcid":false,"given":"Tengku Ibrahim","family":"Maulana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Teufel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalena","family":"Cipriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Roosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lazarevski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francijna E.","family":"van den Hil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Scheller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Orlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hudecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Alb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Loskill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stem.2024.04.018_bib1","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-023-03368-2","article-title":"CAR-T cell therapy: a game-changer in cancer treatment and beyond","author":"Utkarsh","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.stem.2024.04.018_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/10428194.2023.2276676","article-title":"BCMA CAR-T cells in multiple myeloma-ready for take-off?","volume":"65","author":"Scheller","year":"2024","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.stem.2024.04.018_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.coi.2018.03.002","article-title":"Driving CARs on the uneven road of antigen heterogeneity in solid tumors","volume":"51","author":"Chen","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.stem.2024.04.018_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.omto.2022.03.009","article-title":"CAR T\u00a0cell therapy and the tumor microenvironment: Current challenges and opportunities","volume":"25","author":"Kankeu Fonkoua","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.stem.2024.04.018_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.omtm.2022.08.008","article-title":"Applying a clinical lens to animal models of CAR-T cell therapies","volume":"27","author":"Duncan","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.stem.2024.04.018_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","article-title":"CAR T\u00a0cell therapy for patients with solid tumours: key lessons to learn and unlearn","volume":"21","author":"Albelda","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.stem.2024.04.018_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0167-1","article-title":"Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice","volume":"50","author":"Choi","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.stem.2024.04.018_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","article-title":"Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy","volume":"22","author":"Morris","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.stem.2024.04.018_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.addr.2021.03.015","article-title":"Immunocompetent cancer-on-chip models to assess immuno-oncology therapy","volume":"173","author":"Maulana","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.stem.2024.04.018_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s42003-021-02977-3","article-title":"Human immunocompetent choroid-on-chip: a novel tool for studying ocular effects of biological drugs","volume":"5","author":"Cipriano","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.stem.2024.04.018_bib11","article-title":"Autologous Human Immunocompetent White Adipose Tissue-on-Chip","volume":"9","author":"Rogal","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.stem.2024.04.018_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5907","article-title":"The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on\/off switch for CAR T\u00a0cells","volume":"11","author":"Mestermann","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.stem.2024.04.018_bib13","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.3390\/cancers15143602","article-title":"Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer","volume":"15","author":"\u00d6nder","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.stem.2024.04.018_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf8621","article-title":"Immunotherapy of non-Hodgkin\u2019s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor\u2013modified T\u00a0cells","volume":"8","author":"Turtle","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.stem.2024.04.018_bib15","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR\u2013T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.stem.2024.04.018_bib16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.stem.2024.04.018_bib17","first-page":"233","article-title":"Beyond chemicals: Opportunities and challenges of integrating non-chemical stressors in adverse outcome pathways","volume":"41","author":"Clerbaux","year":"2024","journal-title":"ALTEX"},{"key":"10.1016\/j.stem.2024.04.018_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/1547691X.2024.2345158","article-title":"Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway concept","author":"Alb","year":"2024","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.stem.2024.04.018_bib19","article-title":"Time to evolve: predicting engineered T\u00a0cell-associated toxicity with next-generation models","volume":"10","author":"Donnadieu","year":"2022","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.stem.2024.04.018_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T\u00a0cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.stem.2024.04.018_bib21","article-title":"Dasatinib for treatment of CAR T-cell therapy-related complications","volume":"10","author":"Baur","year":"2022","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.stem.2024.04.018_bib22","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.ajpath.2012.08.024","article-title":"The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers","volume":"181","author":"Zhang","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.stem.2024.04.018_bib23","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1158\/1078-0432.CCR-16-2083","article-title":"Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues","volume":"23","author":"Balakrishnan","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.stem.2024.04.018_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.stem.2024.04.018_bib25","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T\u00a0cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2024.04.018_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coi.2015.01.011","article-title":"Targeting the tumor vasculature to enhance T\u00a0cell activity","volume":"33","author":"Lanitis","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.stem.2024.04.018_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri.2017.145","article-title":"Improving immune\u2013vascular crosstalk for cancer immunotherapy","volume":"18","author":"Huang","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.stem.2024.04.018_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41587-022-01397-w","article-title":"Uncovering the mode of action of engineered T\u00a0cells in patient cancer organoids","volume":"41","author":"Dekkers","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stem.2024.04.018_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1248","article-title":"Patient-derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR-T cells in\u00a0vitro","volume":"10","author":"Yu","year":"2021","journal-title":"Clin. Transl. Immunology"},{"key":"10.1016\/j.stem.2024.04.018_bib30","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1038\/s41596-020-0402-9","article-title":"Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T\u00a0cell testing","volume":"15","author":"Jacob","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stem.2024.04.018_bib31","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/s41467-021-21445-4","article-title":"Acquired cancer cell resistance to T\u00a0cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation","volume":"12","author":"Arenas","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2024.04.018_bib32","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100928","article-title":"3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids","volume":"38","author":"Schnalzger","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.stem.2024.04.018_bib33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/cancers16010168","article-title":"Precision Immunotherapy Utilizing Adapter CAR-T Cells (AdCAR-T) in Metastatic Breast Cancer Leads to Target Specific Lysis","volume":"16","author":"\u00d6nder","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.stem.2024.04.018_bib34","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","article-title":"Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia","volume":"6","author":"Teachey","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.stem.2024.04.018_bib35","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.4049\/jimmunol.2001249","article-title":"Biomarkers for Predicting Cytokine Release Syndrome following CD19-Targeted CAR T Cell Therapy","volume":"206","author":"Tedesco","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.stem.2024.04.018_bib36","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/s41591-020-1061-7","article-title":"Characteristics of anti-CD19 CAR T\u00a0cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas","volume":"26","author":"Deng","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2024.04.018_bib37","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","article-title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor\u2013modified T-cell therapy","volume":"130","author":"Hay","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.stem.2024.04.018_bib38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T\u00a0cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2024.04.018_bib39","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2024.04.018_bib40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.stem.2024.04.018_bib41","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T\u00a0cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2024.04.018_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy \u2014 assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.stem.2024.04.018_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hon.2595","article-title":"Managing the toxicities of CAR T-cell therapy","volume":"37","author":"Neelapu","year":"2019","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.stem.2024.04.018_bib44","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2024.04.018_bib45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2024.04.018_bib46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41591-018-0041-7","article-title":"CAR T cell\u2013induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade","volume":"24","author":"Giavridis","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2024.04.018_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s13046-021-02148-6","article-title":"Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies","volume":"40","author":"Xiao","year":"2021","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.stem.2024.04.018_bib48","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.stemcr.2019.06.004","article-title":"Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture","volume":"13","author":"Halloin","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stem.2024.04.018_bib49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","article-title":"Navigating CAR-T cells through the solid-tumour microenvironment","volume":"20","author":"Hou","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.stem.2024.04.018_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax7969","article-title":"Gasdermin E\u2013mediated target cell pyroptosis by CAR T\u00a0cells triggers cytokine release syndrome","volume":"5","author":"Liu","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.stem.2024.04.018_bib51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.stem.2024.04.018_bib52","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.stem.2024.04.018_bib53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","article-title":"A more efficient method to generate integration-free human iPS cells","volume":"8","author":"Okita","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.stem.2024.04.018_bib54","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1038\/s41598-020-63710-4","article-title":"WAT-on-a-chip integrating human mature white adipocytes for mechanistic research and pharmaceutical applications","volume":"10","author":"Rogal","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.stem.2024.04.018_bib55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev.matsci.28.1.153","article-title":"Soft lithography","volume":"28","author":"Xia","year":"1998","journal-title":"Annu. Rev. Mater. Sci."},{"key":"10.1016\/j.stem.2024.04.018_bib56","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.biomaterials.2012.12.024","article-title":"The use of agarose microwells for scalable embryoid body formation and cardiac differentiation of human and murine pluripotent stem cells","volume":"34","author":"Dahlmann","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.stem.2024.04.018_bib57","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/nprot.2013.153","article-title":"In\u00a0vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture","volume":"8","author":"Miyoshi","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stem.2024.04.018_bib58","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.stemcr.2017.03.009","article-title":"Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In\u00a0Vitro Pluripotency Assays","volume":"8","author":"Bouma","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stem.2024.04.018_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.diff.2013.01.001","article-title":"Polycistronic lentivirus induced pluripotent stem cells from skin biopsies after long term storage, blood outgrowth endothelial cells and cells from milk teeth","volume":"85","author":"Dambrot","year":"2013","journal-title":"Differentiation"},{"key":"10.1016\/j.stem.2024.04.018_bib60","first-page":"51","article-title":"The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands","volume":"18","author":"Freund","year":"2010","journal-title":"Neth. Heart J."},{"key":"10.1016\/j.stem.2024.04.018_bib61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.fsigen.2014.01.008","article-title":"Comparing six commercial autosomal STR kits in a large Dutch population sample","volume":"10","author":"Westen","year":"2014","journal-title":"Forensic Sci. Int. Genet."},{"key":"10.1016\/j.stem.2024.04.018_bib62","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/nprot.2014.102","article-title":"Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells","volume":"9","author":"Orlova","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stem.2024.04.018_bib63","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/1078-0432.CCR-13-0330","article-title":"Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T\u00a0cells","volume":"19","author":"Hudecek","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.stem.2024.04.018_bib64","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2015.247","article-title":"Chimeric antigen receptor-modified T\u00a0cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in\u00a0vivo","volume":"30","author":"Sommermeyer","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2024.04.018_bib65","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00018-017-2686-7","article-title":"CD4 and CD8\u00a0T lymphocyte interplay in controlling tumor growth","volume":"75","author":"Ostroumov","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.stem.2024.04.018_bib66","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T\u00a0cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"}],"container-title":["Cell Stem Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590924001450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590924001450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:31:28Z","timestamp":1762561888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590924001450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1934590924001450"],"URL":"https:\/\/doi.org\/10.1016\/j.stem.2024.04.018","relation":{},"ISSN":["1934-5909"],"issn-type":[{"value":"1934-5909","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells","name":"articletitle","label":"Article Title"},{"value":"Cell Stem Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2024.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}